What Makes Us Better

Allergy Canada recognizes your needs.  Our mission is to consistently supply the best quality allergy material, to set the highest standards and to promote the allergist and the best practice of allergy in Canada.

Allergy Canada Ltd. represents ALK-Abelló in Canada.  ALK-Abelló is the world's leading innovator and manufacturer of allergy vaccines, with subsidiaries and representatives in over 20 countries.

Allergy Canada re-invests a minimum of 12% of revenues into research and education.  Our products were used in, and our collaborators recently published, the first papers from the Prevention of Asthma Trial (PAT).  The study concluded that allergy immunotherapy prevents the onset of asthma in children with allergic rhinitis.  Allergy Canada is currently partnered with the world's largest study on the prevention of allergy.

Allergy Canada Ltd. has a Class A Laboratory (Class 100) designed for the preparation of allergy vaccines.  Our facility is operated by university-educated, highly trained formulators and scientists, and is inspected, licensed and monitored by Health Canada.

We take pride in offering the gold-standard of Hymenoptera venom products and provide the only tested and proven House-Dust-Mite bedding encasings in Canada.  Our microbiological testing is done externally; independent and separately regulated by Health Canada.  Our security-sealed orders are shipped throughout Canada by next day courier.  We consistently use the same high-quality antigens in all induction and maintenance treatments.  Our satisfaction comes from working closely with allergists, interactively learning what the needs of their patients are, and working together to bolster the best-practice of allergy immunotherapy within medicine in Canada.

We would like to take this opportunity to thank you for your continued support and feedback.    We will continue to focus on providing physicians and patients an extensive product line, professional service, unique products and continued scientific innovation.